Clinical and immunological features of the variants of the course of recurrent genital herpes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The variety of clinical forms of genital herpes (GH) is associated with the virological properties of infectious agents (herpes simplex virus type 1 or 2), which have immunosuppressive properties and mechanisms for escaping the body’s immune surveillance. Chronic infection leads to immunodeficiency, which is manifested by a decrease in the functional activity of immunocompetent cells, dysregulation of immune mechanisms and, as a consequence, ineffectiveness of the antiviral response mechanisms. These factors are responsible for long-term persistence, reactivation of the virus and recurrence of the disease.Objective. Identification of the features of clinical manifestations, immune and cytokine statuses of patients with arrhythmic, monotonous and subsiding variants of the course of GH in order to their use in clinical diagnostic algorithms for the appointment of adequate immunotropic therapy.Methods. 58 women and 34 men aged 26 to 45 years with GH caused by the herpes simplex virus type 1 or 2 voluntarily participated in the study. All patients were divided into groups: group I - with arrhythmic course of disease (the duration of remission between relapses from 2-3 weeks to 2-3 months), group II - with monotonous (6-8 relapses per year with remissions lasting 2-6 weeks), and group III - with subsiding ones (increase in the duration of remission from 3 months to 9 months over time). Clinical manifestations, immune and cytokine statuses were analyzed.Results. According to the severity of clinical manifestations, GH relapses were 2-2.5 times more severe in the arrhythmic variant compared to the monotonous and subsiding variants. The monotonous course occupied an intermediate place, but was characterized by the most pronounced feeling of general malaise; clinical symptoms were less severe in subsiding variant of relapse. In an arrhythmic course of GH, T-cell cytotoxic reactions were activated (the blood CD8 and CD4 levesl increased, the immunoregulatory index decreased); the total pool of T-lymphocytes (CD3), NK-cells (CD16), the α-, β-, γ-interferon, interleukin-2 and tumor necrosis factor α levels decreased. In a monotonous variant of GH relapse, changes in the immune status and cytokine content were less pronounced; in a subsiding variant, an increase in the level with normal immunograms was characteristic.Conclusion. The results of the study indicate the activation of antiviral immunity in the subsiding course of recurrent GH and its exhaustion - in arrhythmic one. The revealed features of clinical manifestations, immune and cytokine statuses of patients with arrhythmic, monotonous and subsiding variants of the course of GH make it possible to supplement the clinical diagnostic capabilities with adequate immunotropic therapy

Full Text

Restricted Access

About the authors

N. V Shperling

REAVIZ Medical University; State Scientific-Research Test Institute of Military Medicine

Email: shperling2@yandex.ru
Dr. Sci. (Med.), Professor at the Department of Clinical Medicine

I. A Shperling

State Scientific-Research Test Institute of Military Medicine

References

  1. Андреева О.Г., Муравська Л.В., Дьяченко П.А. и др. Сучасні проблеми, діагностика та лікування герпесвірусних інфекцій. Актуальна інфектологія. 2020;8(3-4):63-7. doi: 10.22141/2312-413x.8.3-4.2020.212664.
  2. Белова А.В., Асцатурова О.Р, Науменко Н.С., Никонов А.П. Генитальный герпес и беременность. Архив акушерства и гинекологии им. В.Ф. Снегирева. 2017;4(3):124-30
  3. Гребенюк В.Н. Рецидивирующий генитальный герпес. Клиника, особенности иммунореактивности, лечение. Дисс. докт. мед. наук. М., 1983
  4. Дидковский Н.А., Малашенкова И.К., Сарсания Ж.Ш. и др. Герпетическая инфекция тяжелого течения. Терапевтический архив. 2007;(11): 52-7
  5. Ершов Ф.И., Киселев О.И. Интерфероны и их индукторы (от молекул до лекарств). М., 2005
  6. Новицкий В.В., Решетников В.И., Рязанцева Н.В. и др. Изменения продукции иммунорегуляторных цитокинов мононуклеарами крови при хронической герпес-вирусной инфекции. Клиническая лабораторная диагностика. 2005;(5);43-5
  7. Пестрикова Т.Ю., Юрасова Е.А., Юрасов И.В., Котельникова А.В. Основные принципы веде ния пациенток с генитальным герпесом (обзор литературы). Гинекология. 2019;21(1):80-5.
  8. Скрипкин Ю.А., Козырева О.В., Матушевская Е.В., Ковальчук Л.В. Иммунологические аспекты патогенеза рецидивирующего генитального герпеса. Герпес. 2008;(1):4-6.
  9. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд, перераб. и доп. М., 2016.
  10. Халдин А.А., Самгин М.А., Львов А.Н. Алгоритм ведения больных рецидивирующим про стым герпесом: от науки к практике. Герпес. 2008;(1):21-4.
  11. Шперлинг Н.В. Клинико-иммунологические особенности и рациональная терапия рецидивирующего генитального герпеса. Герпес. 2008;(2):23-6.
  12. Carr D.J., Tomanek L. Herpes simplex virus and the chemokines that mediate the inflammation. Curr Top Microbiol immunol. 2006;303:47-65. doi: 10.18821/2313-8726-2017-4-3-124-130.
  13. Trgovcich J., Johnson D., Roizman B. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L) 41 genes of herpes simplex virus 1. J. Virol 2002;76(14):6974-86. doi: 10.1128/jvi.76.14.6974-6986.2002.
  14. Stary A. Herpes Genitalis. European Handbook of Dermatological Treatments. 3 Ed. Springer-Verlag Berlin Heidelberg. 2015. Р. 357-72.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies